Schedule 13D ownership disclosure

Oramed Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 68403P203

Event date: 2008-07-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001178913-14-003882
Form type
SC 13D
Filer
ORAMED PHARMACEUTICALS INC.
CIK
CIK 1176309
Filed
Dec 15, 2014
Reporting period
Jul 14, 2008
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub